Koyfin Home > Directory > Health Care > Amag Pharmaceuticals > Gross Margin

Amag Pharmaceuticals Gross Margin Chart (AMAG)

Amag Pharmaceuticals annual/quarterly Gross Margin from 2010 to 2020. Gross margin is a company's total sales revenue minus its cost of goods sold (COGS), divided by total sales revenue, expressed as a percentage. The higher the percentage, the more the company retains on each dollar of sales, to service its other costs and debt obligations.
  • Amag Pharmaceuticals Gross Margin for the quarter ending June 06, 2020 was $50m a -26.16% decrease of -13m year over year
  • Amag Pharmaceuticals Gross Margin for the last 12 months ending June 06, 2020 was $53m a -8.88% decrease of -5m year over year
  • Amag Pharmaceuticals Annual Gross Margin for 2019 was $54m a 11.14% increase of 6m from 2018
  • Amag Pharmaceuticals Annual Gross Margin for 2018 was $48m a -33.49% decrease of -16m from 2017
  • Amag Pharmaceuticals Annual Gross Margin for 2017 was $65m a -2.44% decrease of -2m from 2016
Other Margins & Efficiency Metrics:
  • Amag Pharmaceuticals EBITDA Margin for the quarter ending December 12, 2018 was $0m a -26,297.24% decrease of -25m year over year
  • Amag Pharmaceuticals Return on Capital % for the quarter ending September 09, 2018 was -1.36 a 8.15% decrease of -0.11 year over year
  • Amag Pharmaceuticals Return on Equity % for the quarter ending September 09, 2018 was -34.75 a 105.01% decrease of -36.49 year over year
View Chart On Koyfin

Quarterly AMAG Gross Margin Data

06/2020$50m
03/2020$50m
12/2019$35m
09/2019$63m
06/2019$56m
03/2019$59m
12/2018$60m
09/2018$57m
06/2018$40m
03/2018$40m

Annual AMAG Gross Margin Data

2019$54m
2018$48m
2017$65m
2016$66m
2015$72m
2014$74m
2013$74m
2012$64m
2011$16m
2010$35m